Antibodies to exenatide did not cross-react with human GLP-1 or glucagon or alter the efficacy or safety of exenatide

M. Fineman, K. Mace, M. Diamant, T. Darsow, B. Cirincione, T.B. Porter, M. Trautmann

Research output: Contribution to journalMeeting AbstractOther research output

44 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)858
JournalDiabetologia
Volume53
DOIs
Publication statusPublished - 2010

Cite this